Gene · 710
Papers4,575
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 4,575
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A patient with hereditary angioedema (HAE) with normal C1-INH and SLE with pregnancy. | J Allergy Clin Immunol Glob | 2023 | 37780110 | PubTator, text mining | PubMed |
| Validation of a suspicion index to identify patients at risk for hereditary angioedema. | J Allergy Clin Immunol Glob | 2023 | 37780104 | PubTator, text mining | PubMed |
| Fallopian tube lesions as potential precursors of early ovarian cancer: a comprehensive proteomic analysis. | Cell Death Dis | 2023 | 37775701 | PubTator, text mining | PubMed |
| Impact of Treatment with Ustekinumab on Severe Infections in a Patient with Uncontrolled Psoriasis and Late-Onset Combined Primary Immunodeficiency: Case Report. | Pathogens | 2023 | 37764964 | PubTator, text mining | PubMed |
| Comparative Proteomic Analysis of Exosomes Derived from Patients Infected with Non-Tuberculous Mycobacterium and Mycobacterium tuberculosis. | Microorganisms | 2023 | 37764178 | PubTator, text mining | PubMed |
| Complement System Proteins in the Human Aqueous Humor and Their Association with Primary Open-Angle Glaucoma. | J Pers Med | 2023 | 37763167 | PubTator, text mining | PubMed |
| Relationship between Disease Characteristics and Circulating Interleukin 6 in a Well-Characterized Cohort of Patients with Systemic Lupus Erythematosus. | Int J Mol Sci | 2023 | 37762312 | PubTator, text mining | PubMed |
| Serum Extracellular Vesicle-Derived hsa-miR-2277-3p and hsa-miR-6813-3p Are Potential Biomarkers for Major Depression: A Preliminary Study. | Int J Mol Sci | 2023 | 37762202 | PubTator, text mining | PubMed |
| Characteristics and Drug Utilization of Patients with Hereditary Angioedema in Italy, a Real-World Analysis. | Healthcare (Basel) | 2023 | 37761706 | PubTator, text mining | PubMed |
| Viral SERPINS-A Family of Highly Potent Immune-Modulating Therapeutic Proteins. | Biomolecules | 2023 | 37759793 | PubTator, text mining | PubMed |
| Single-Cell Transcriptomics of Mtb/HIV Co-Infection. | Cells | 2023 | 37759517 | PubTator, text mining | PubMed |
| Current Understanding of Complement Proteins as Therapeutic Targets for the Treatment of Immunoglobulin A Nephropathy. | Drugs | 2023 | 37747686 | PubTator, text mining | PubMed |
| Complement and coagulation cascades pathway-related signature as a predictor of immunotherapy in metastatic urothelial cancer. | Aging (Albany NY) | 2023 | 37747262 | PubTator, text mining | PubMed |
| Could it be hereditary angioedema?-Perspectives from different medical specialties. | Clin Transl Allergy | 2023 | 37746796 | PubTator, text mining | PubMed |
| Evaluation of patient-reported outcome measures for on-demand treatment of hereditary angioedema attacks and design of KONFIDENT, a phase 3 trial of sebetralstat. | Clin Transl Allergy | 2023 | 37746795 | PubTator, text mining | PubMed |
| Patient-physician interactions in hereditary angioedema-Key learnings from the coronavirus disease 2019 pandemic. | Clin Transl Allergy | 2023 | 37746793 | PubTator, text mining | PubMed |
| Modelling and analysis of the complement system signalling pathways: roles of C3, C5a and pro-inflammatory cytokines in SARS-CoV-2 infection. | PeerJ | 2023 | 37744234 | PubTator, text mining | PubMed |
| Acquired Non-histaminergic Angioedema With C1q Autoantibody and Urticaria: A Case Report. | Cureus | 2023 | 37736455 | PubTator, text mining | PubMed |
| Real-world experience of hereditary angioedema (HAE) in Mexico: A mixed-methods approach to describe epidemiology, diagnosis, and treatment patterns. | World Allergy Organ J | 2023 | 37727628 | PubTator, text mining | PubMed |
| Human plasma kallikrein: roles in coagulation, fibrinolysis, inflammation pathways, and beyond. | Front Physiol | 2023 | 37711466 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/710/papers?page=22